spineart
-
Spine
SPINEART RECEIVES CLEARANCE FROM THE FDA TO MARKET ITS TI-LIFE TECHNOLOGY 3D TITANIUM INTERBODY DEVICES
Spineart is pleased to announce that it has received 510(k) clearance from the FDA to market its new JULIET®Ti lumbar interbody systems…
Read More » -
Spine
SPINEART LAUNCHES NEW TI-LIFE TECHNOLOGY 3D TITANIUM INTERBODY DEVICES
13 JULY 2016 Spineart is pleased to announce that it has received CE marking for its new JULIET®Ti lumbar interbody systems. The…
Read More » -
Spine
SPINEART ANNOUNCES PUBLICATION OF CLINICAL DATA FOR ITS BAGUERA®C ARTIFICAL CERVICAL DISC PROSTHESIS
5 JULY 2016 Spineart announced today the results published in the Journal of Spine from a multicenter European prospective…
Read More » -
Financial
Spineart USA First Quarter 2016
June 28, 2016 Activity Our revenues in the US grew 44% in the first quarter of 2016 compared to…
Read More » -
Top Stories
Spineart Announces Successful completion of 15,000th Implantation of Baguera C Artificial Cervical Disc
13 JUNE 2016 Spineart is pleased to announce that, as of the 1st of June 2016, more than 15’000…
Read More » -
Spine
Why You Need a UDI-Ready Line… or Even Better, a Sterile-Packed One
Written by: Jérôme Trividic UDI, the FDA Unique Device Identification System was signed into law back in 2007. Yet, eight years…
Read More » -
Hospitals
SPINEART ANNOUNCES CHINA CFDA CLEARANCE OF EXTENSIVE FUSION PORTFOLIO
It includes cervical cages, plates and cage-plates (TRYPTIK®), lumbar cages (JULIET® PLIF, TLIF, ALIF) and the renowned thoracolumbar osteosynthesis system,…
Read More » -
Hospitals
COMPLETION OF THE REGULATORY APPROVAL PROCESS IN INDIA
Spineart announced the completion of the regulatory approval process in India for its ROMEO®2 thoraco-lumbar system and its unique ROMEO®2 MIS…
Read More »